Increased rate of any retinopathy risk in patients with masked hypertension

References

• Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259(2):225–28. doi:10.1001/jama.1988.03720020027031.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193–98. doi:10.1097/HJH.0b013e3282ef6185.
   PubMed Web of Science ®Google Scholar
• Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torppedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19(3):243–50. doi:10.1016/j.amjhyper.2005.09.018.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F. Short- and long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens. 2008;22(6):408–14. doi:10.1038/jhh.2008.6.
   PubMed Web of Science ®Google Scholar
• Asayama K, Thijs L, Li Y, Gu Y-M, Hara A, Liu Y-P, Zhang Z, Wei -F-F, Lujambio I, Mena LJ, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension. 2014;64(5):935–42. doi:10.1161/HYPERTENSIONAHA.114.03614.
   PubMed Web of Science ®Google Scholar
• Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40(6):795–96. doi:10.1161/01.HYP.0000038733.08436.98.
   PubMed Web of Science ®Google Scholar
• O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68. doi:10.1097/HJH.0b013e328363e964.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52–58. doi:10.1038/ajh.2010.203.
   PubMed Web of Science ®Google Scholar
• Peacock J, Diaz KM, Viera AJ, Schwartz JE, Shimbo D. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28(9):521–28. doi:10.1038/jhh.2014.9.
   PubMed Web of Science ®Google Scholar
• Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26(9):1715–25. doi:10.1097/HJH.0b013e3282fbcedf.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure The JNC 7 report. JAMA. 2003;289:2560–72.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021–104. doi:10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Walsh JB. Hypertensive retinopathy. Description, classification, and prognosis. Ophthalmology. 1982;89:1127–31. doi:10.1016/S0161-6420(82)34664-3.
   PubMed Web of Science ®Google Scholar
• Fraser-Bell S, Symes R, Vaze A. Hypertensive eye disease: a review. Clin Exp Ophthalmol. 2017;45:45–53. doi:10.1111/ceo.12905.
   PubMed Web of Science ®Google Scholar
• Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1974;268:336–45. doi:10.1097/00000441-197412000-00004.
   PubMed Web of Science ®Google Scholar
• Aissopou EK, Papathanassiou M, Nasothimiou EG, Konstantonis GD, Tentolouris N, Theodossiadis PG, Papaioannou TG, Sfikakis PP, Protogerou AD. The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years. J Hypertens. 2015;33:2303–09.
   PubMed Web of Science ®Google Scholar
• Dodson PM, Lip GY, Eames SM, Gibson JM, Beevers DG. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens. 1996;10:93–98.
   PubMed Web of Science ®Google Scholar
• Hyman BN. The eye as a target organ: an updated classification of hypertensive retinopathy. Clin Hypertens (Greenwich). 2000;2:194–97.
   PubMedGoogle Scholar
• Wong TY, Klein R, Sharrett AR, Manolio TA, Hubbard LD, Marino EK, Kuller L, Burke G, Tracy RP, Polak JF, et al. The prevalence and risk factors of retinal microvascular abnormalities in older persons: the Cardiovascular Health Study. Ophthalmology. 2003;110:658–66.
   PubMed Web of Science ®Google Scholar
• McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BEK, Wang JJ, Mitchell P, Vingerling JR, de Jong PTVM, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009;170:1323–32.
   PubMed Web of Science ®Google Scholar
• Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura JS, Martell N, Garcia-Puig J, Deanfields J, Williams B. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014;35:3304–12. doi:10.1093/eurheartj/ehu016.
   PubMed Web of Science ®Google Scholar
• Tso MOM, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology. 1982;89:1132–45. doi:10.1016/S0161-6420(82)34663-1.
   PubMed Web of Science ®Google Scholar